Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/News Feed/STANCE trial hits enrollment milestone, advancing GalaFLEX LITE™ use in breast revision surgery.
BDX
$189.42
-$0.79 -0.42%

STANCE trial hits enrollment milestone, advancing GalaFLEX LITE™ use in breast revision surgery.

Market News
27 Aug 2026
PRNewsWire
View Source
Bullish
pluang ai news

The STANCE clinical trial evaluating BD's GalaFLEX LITE™ Scaffold for breast revision surgery in capsular contracture has surpassed its first enrollment milestone with 274 patients treated at 33 U.S. sites, exceeding 50% of planned enrollment. This trial aims to generate clinical evidence supporting the scaffold's safety and efficacy to reduce recurrence of capsular contracture, a common complication in implant-based breast surgery. Results from this study could support FDA approval for a new breast surgery indication, potentially improving outcomes for patients facing this challenging condition. The study continues with ongoing patient follow-up and interim analyses.

More News (BDX)

BD to present at Wells Fargo Healthcare Conference on Sept 9, 2026, with live webcast available.

BD to present at Wells Fargo Healthcare Conference on Sept 9, 2026, with live webcast available.

BD (Becton, Dickinson and Company), a global medical technology leader, announced it will present at the Wells Fargo 21st Annual Healthcare Conference on September 9, 2026, at 9:30 a.m. Eastern Time. The presentation will be webcast live and availabl...

Market News
Neutral
1 day ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App